The above results illustrated that FABP7 and NDUFAB1 could serve as predictive biomarkers in immunotherapies for breast cancer, which also suggested a significant correlation of FABP7 and NDUFAB1 with the tumour immune microenvironment (TIME). This evidence concerns the gene NDUFAB1 and neoplasm.